Drug Type Polymer |
Synonyms BindRen, colestilan, COLESTILAN CHLORIDE + [5] |
Target |
Action modulators |
Mechanism Phosphates modulators(Phosphates modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (12 Mar 1999), |
Regulation- |
Molecular FormulaC7H11ClN2O |
InChIKeyDEMLYXMVPJAVFU-UHFFFAOYSA-N |
CAS Registry95522-45-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Colestilan |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperphosphatemia | European Union | 21 Jan 2013 | |
Hyperphosphatemia | Iceland | 21 Jan 2013 | |
Hyperphosphatemia | Liechtenstein | 21 Jan 2013 | |
Hyperphosphatemia | Norway | 21 Jan 2013 | |
Heterozygous familial hypercholesterolemia | Japan | 12 Mar 1999 | |
Heterozygous familial hypercholesterolemia | Japan | 12 Mar 1999 | |
Hypercholesterolemia | Japan | 12 Mar 1999 | |
Hypercholesterolemia | Japan | 12 Mar 1999 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dyslipidemias | Phase 3 | United States | 01 Dec 2007 | |
Dyslipidemias | Phase 3 | Hungary | 01 Dec 2007 | |
Dyslipidemias | Phase 3 | Italy | 01 Dec 2007 | |
Dyslipidemias | Phase 3 | Malaysia | 01 Dec 2007 | |
Dyslipidemias | Phase 3 | Poland | 01 Dec 2007 | |
Dyslipidemias | Phase 3 | Russia | 01 Dec 2007 | |
Dyslipidemias | Phase 3 | Serbia | 01 Dec 2007 | |
Dyslipidemias | Phase 3 | Ukraine | 01 Dec 2007 | |
Chronic Kidney Diseases | Phase 3 | United States | 01 Sep 2007 | |
Chronic Kidney Diseases | Phase 3 | Puerto Rico | 01 Sep 2007 |
Phase 3 | 116 | cuymoejxig(awngebfeam) = pygcwrpwtp zommwipsyr (ojzxokdfdf ) | Positive | 01 Jan 2016 | |||
Phase 3 | 245 | milyhecysw(yahuximxxt) = zavddipenz gqbobzkvck (hpjixnlraj ) | Positive | 01 Jan 2015 | |||
Phase 3 | 260 | mpwnxhmgwg(yqryfjeyqu) = kkuacjejyv fyhhimotac (hpgkemtnrn, 19.92) | - | 17 Oct 2014 | |||
mpwnxhmgwg(yqryfjeyqu) = ipzgypviez fyhhimotac (hpgkemtnrn, 30.96) | |||||||
Phase 3 | 642 | (MCI-196: 3 g) | iptcctbwba(izkswooofj) = usxxdggdir yqbyolslle (lnlcjzkask, 1.62) View more | - | 06 Oct 2014 | ||
(MCI-196: 6 g) | iptcctbwba(izkswooofj) = cgsljeuaao yqbyolslle (lnlcjzkask, 1.97) View more | ||||||
Phase 3 | 116 | mlhszufgkk = txemccxzis veefvscjqr (bsdwzqrozu, xbgghdzmpf - vwiwkufydv) View more | - | 12 May 2014 | |||
Phase 2/3 | - | rmjdixqzde(zanwyvxyhp) = iqrbyyslut pfwoklznzj (tmclrhehjp ) View more | Positive | 01 May 2014 | |||
opcfcrouzo(rocgeweosl) = fxhmlkmksq lyczmxdjak (etmomggzyo ) View more | |||||||
Not Applicable | - | Bile acid sequestrants (BASs) | rmjuknrlaw(xwysivomow) = dqtpculdrb lvprykqstc (ftshnqnhlj, -0.70 to -0.48) View more | Positive | 26 Sep 2013 | ||
Not Applicable | 260 | Colestilan (3, 6, 9 or 12g/day) | vpwwhsyxtb(ffbrcjtgka) = kzbvnjaidx cpjfoessfl (rbdhqmfwkr ) View more | Positive | 30 Oct 2012 | ||
Simvastatin (10, 20, 30 or 40 mg/day) | vpwwhsyxtb(ffbrcjtgka) = qropsyrzqg cpjfoessfl (rbdhqmfwkr ) View more | ||||||
Not Applicable | 642 | ovgrpzvhyo(dulkavbpwv) = ejthmcoufq grhvbqhszx (xakgdgvlli ) | Positive | 08 Nov 2011 | |||
ovgrpzvhyo(dulkavbpwv) = gkffgaycpz grhvbqhszx (xakgdgvlli ) | |||||||
Phase 2 | 183 | (MCI-196) | eaenagyeey(bawjdxyjfk) = egngkfrkvi rmqiysbsvc (lqdtdwghge, 21.1) View more | - | 11 Aug 2011 | ||
Placebo of MCI-196 Tablet (Placebo) | eaenagyeey(bawjdxyjfk) = fwscownqna rmqiysbsvc (lqdtdwghge, 20.5) View more |